anti-Mullerian hormone receptor type 2
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The AMHR2 gene provides instructions for making the anti-Müllerian hormone (AMH) receptor type 2, which is involved in male sex differentiation. The AMH receptor type 2 is found on the surface of Müllerian duct cells. The Müllerian duct, found in both male and female fetuses, is the precursor to the female reproductive organs. During development of male fetuses, cells of the testes release a protein called the AMH protein. The AMH protein attaches (binds) to the AMH receptor type 2, which signals self-destruction (apoptosis) of the Müllerian duct cells. As a result, the Müllerian duct breaks down (regresses) in males. In females, who do not produce the AMH protein during fetal development, the Müllerian duct becomes the uterus and fallopian tubes.
Video picks for GenesVideo library
Normal function
The AMHR2 gene provides instructions for making the anti-Müllerian hormone (AMH) receptor type 2, which is involved in male sex differentiation. The AMH receptor type 2 is found on the surface of Müllerian duct cells. The Müllerian duct, found in both male and female fetuses, is the precursor to the female reproductive organs. During development of male fetuses, cells of the testes release a protein called the AMH protein. The AMH protein attaches (binds) to the AMH receptor type 2, which signals self-destruction (apoptosis) of the Müllerian duct cells. As a result, the Müllerian duct breaks down (regresses) in males. In females, who do not produce the AMH protein during fetal development, the Müllerian duct becomes the uterus and fallopian tubes.
Conditions referring to this gene or chromosome
Other names
AMH type II receptor
AMHR
AMHR2_HUMAN
anti-Muellerian hormone type II receptor
anti-Muellerian hormone type-2 receptor
anti-Mullerian hormone receptor type II
anti-Mullerian hormone receptor, type II
MIS type II receptor
MISR2
MISRII
MRII
Mullerian inhibiting substance type II receptor
Patient picks for Genes

Hormones
Insulin resistance: the common thread linking metabolic conditions
You may have come across the term “insulin resistance” - particularly if you’ve been having conversations about weight and metabolic health - but be a little unclear about what it actually is. Whilst it’s easy to think insulin resistance just means reduced glucose control, it’s actually far more complex than that. Dr Nienke Lees, Women's Health Service Lead, Genwell UK, explains what it means and how it connects conditions including type 2 diabetes, fatty liver disease, cardiovascular disease, and PCOS.
by Dr Nienke Lees

Men's health
Is 'male menopause' real?
Menopause is a natural stage of life that women go through as they age. During this time, their reproductive hormone levels fluctuate and gradually decline, causing a range of physical and emotional symptoms. But can men experience something similar? Often referred to as ‘male menopause’, hormonal changes as men get older can also affect their health and wellbeing. We explore the symptoms, causes, and science behind 'male menopause' and why it deserves more attention.
by Victoria Raw

Diabetes
Changes in type 2 diabetes care - what it means for you
If you are living with type 2 diabetes your treatment may soon change to be tailored around you and your specific needs - which will help improve your long-term health. Read on to find out what the changes are and what they mean for you.
by Lawrence Higgins

General health and lifestyle
Can a pharmacist prescribe antibiotics?
You may be unaware that some pharmacists can provide you with medicine for a range of health conditions. In this article, we break down which treatments they may be able to offer you.
by Victoria Raw

Diabetes
MHRA approves teplizumab to delay progression of type 1 diabetes
Teplizumab (Tzield) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to help delay the onset of Stage 3 type 1 diabetes (T1D). Read on to see what this means if you are prescribed teplizumab and what it does for you.
by Lawrence Higgins

Hormones
Diabetes insipidus
Diabetes insipidus is a rare condition where the body is unable to control the balance of water. People with diabetes insipidus become very thirsty and pee a lot.
by Dr Doug McKechnie, MRCGP
Related patient information and medicines

Patient information leaflet
Throat cancer
Throat cancer is a general term used to describe cancers of the throat. It is sometimes called laryngeal cancer (cancer of the larynx). Dr Krishna Vakharia, 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer within 28 days of being referred.

Patient information leaflet
Mouth cancer
Mouth cancer is also sometimes called oral cancer. Diagnosing mouth cancer Your healthcare professional may suspect mouth cancer if you have a lesion in your mouth (such as a sore,... Dr Krishna Vakharia , 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or.

Patient information leaflet
Type 2 diabetes treatment
If a high blood sugar level is brought down to a normal level, your symptoms will ease and your risk of long-term complications will be much lower. Managing type 2 diabetes Keeping your blood sugar (glucose) well controlled is key to reducing your risk of long-term complications such as heart, kidney or eye problems. Regardless of whether you need.

Patient information leaflet
Acute pancreatitis
(In chronic pancreatitis, the inflammation is persistent - it tends to cause less intense symptoms than acute pancreatitis but has longer lasting symptoms). How common is acute pancreatitis. Between 13-45 in 100,000 people have acute pancreatitis each year in the UK. Acute pancreatitis has become more common in recent years. This is partly due to.

Patient information leaflet
Pituitary gland disorders
This leaflet gives a brief overview of the pituitary gland and the hormones it makes. The pituitary gland is found at the base of the brain and is 'pea-sized'. The pituitary gland is an overall controller of a number of other glands in the body, overseeing the function of these organs through hormones. Some of the pituitary gland disorders.

Patient information leaflet
Kidney cancer
A description of what kidneys are and how they work is at the bottom of this article. What is kidney cancer. There are several types of kidney cancer but over 9 out of 10 kidney cancers are "renal cell cancer". This is sometimes called renal adenocarcinoma or renal cell carcinoma or hypernephroma. Renal cell cancer This type of cancer develops.
Further reading and references
- anti-Mullerian hormone receptor type 2; MedlinePlus, National Library of Medicine.
- Faure E, Gouedard L, Imbeaud S, Cate R, Picard JY, Josso N, di Clemente N. Mutant isoforms of the anti-Mullerian hormone type II receptor are not expressed at the cell membrane. J Biol Chem. 1996 Nov 29;271(48):30571-5. doi: 10.1074/jbc.271.48.30571.
- Imbeaud S, Belville C, Messika-Zeitoun L, Rey R, di Clemente N, Josso N, Picard JY. A 27 base-pair deletion of the anti-mullerian type II receptor gene is the most common cause of the persistent mullerian duct syndrome. Hum Mol Genet. 1996 Sep;5(9):1269-77. doi: 10.1093/hmg/5.9.1269.
- Josso N, Belville C, di Clemente N, Picard JY. AMH and AMH receptor defects in persistent Mullerian duct syndrome. Hum Reprod Update. 2005 Jul-Aug;11(4):351-6. doi: 10.1093/humupd/dmi014. Epub 2005 May 5.
- Josso N, Picard JY, Imbeaud S, di Clemente N, Rey R. Clinical aspects and molecular genetics of the persistent mullerian duct syndrome. Clin Endocrinol (Oxf). 1997 Aug;47(2):137-44. doi: 10.1046/j.1365-2265.1997.2411044.x. No abstract available.
- Rey R. Anti-Mullerian hormone in disorders of sex determination and differentiation. Arq Bras Endocrinol Metabol. 2005 Feb;49(1):26-36. doi: 10.1590/s0004-27302005000100005. Epub 2006 Mar 16.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

